logo
[breadcrumb_custom]

Tag: (RNAZ)

Finance

TransCode Therapeutics Inc (RNAZ) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. TransCode Therapeutics Inc’s current trading price is -99.84% away from its 52-week high, while its distance from the 52-week low is 1.88%. The stock’s price range over this period has fluctuated between $0.56 and $356.00. The company, operating within the financial sector, had a trading volume of approximately 2.91 million for the day, which was noticeably higher than the average daily share volume of 0.66 million over the last 3 months. TransCode Therapeutics Inc’s market performance has

OPEN Stock
Industry

RNAZ Stock: Exploring TransCode Therapeutics Inc’s Growth

TransCode Therapeutics Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $392.00 on 04/05/23, and the lowest price during the same period was recorded at $0.56 on 02/06/24. 52-week price history of RNAZ Stock Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. TransCode Therapeutics Inc’s current trading price is -99.83% away from its 52-week high, while its distance from the 52-week low is 21.96%. The stock’s price range for this period has remained between $0.56

ZM Stock
Stock

TransCode Therapeutics Inc (RNAZ) Stock: Uncovering 52-Week Market Trends

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. TransCode Therapeutics Inc’s current trading price is -99.85% away from its 52-week high, while its distance from the 52-week low is 6.25%. The stock’s price range during this period has varied between $0.56 and $392.00. The company, active in the Healthcare sector, saw a trading volume of around 0.53 million for the day, considerably lower average daily volume of 0.63 million observed over the last three months. TransCode Therapeutics Inc’s stock has seen a rocky